Authors:
Prabhu Nesargikar
,
B. SpillerCardiff University Institute of Molecular and Experimental Medicine, School of Medicine Cardiff UK

Search for other papers by B. Spiller in
Current site
Google Scholar
PubMed
Close
, and
R. ChavezUniversity Hospital of Wales Cardiff Transplant Unit Cardiff UK

Search for other papers by R. Chavez in
Current site
Google Scholar
PubMed
Close
Open access

Since its discovery in the 19th century, the complement system has developed into a clinically significant entity. The complement system has been implicated in a variety of clinical conditions, from autoimmune diseases to ischemia-reperfusion injury in transplantation. This article charts the historical progress of our understanding of the complement system and provides a synopsis on the activation pathways and its inherent regulators.

  • Schifferli JA et al.: The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315, 488–495 (1986)

    Schifferli J.A. , 'The role of complement and its receptor in the elimination of immune complexes ' (1986 ) 315 N Engl J Med : 488 -495 .

    • Search Google Scholar
  • Davies KA et al.: Complement deficiency and immune complex disease. Springer Semin Immunopathol 15, 397–416 (1994)

    Davies K.A. , 'Complement deficiency and immune complex disease ' (1994 ) 15 Springer Semin Immunopathol : 397 -416 .

    • Search Google Scholar
  • Mevorach D et al.: Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188, 2313–2320 (1998).

    Mevorach D. , 'Complement-dependent clearance of apoptotic cells by human macrophages ' (1998 ) 188 J Exp Med : 2313 -2320 .

    • Search Google Scholar
  • Tauber AI et al.: The birth of immunology. II. Metchnikoff and his critics. Cell Immunol 121, 447–473 (1989).

    Tauber A.I. , 'The birth of immunology. II. Metchnikoff and his critics ' (1989 ) 121 Cell Immunol : 447 -473 .

    • Search Google Scholar
  • Buchner H: Zur Nomenklatur der schutzenden Eiweisskorper. Centr Bakteriol Parasitenk 10, 699–701 (1891).

    Buchner H. , 'Zur Nomenklatur der schutzenden Eiweisskorper ' (1891 ) 10 Centr Bakteriol Parasitenk : 699 -701 .

    • Search Google Scholar
  • Skarnes RC et al.: Antimicrobial factors of normal tissues and fluids. Bacteriol Rev 21, 273–294 (1957).

    Skarnes R.C. , 'Antimicrobial factors of normal tissues and fluids ' (1957 ) 21 Bacteriol Rev : 273 -294 .

    • Search Google Scholar
  • Morgan BP: Complement: Clinical Aspects and Relevance to Disease. Academic Press, UK (1990).

    Morgan B.P. , '', in Complement: Clinical Aspects and Relevance to Disease , (1990 ) -.

  • Kaufmann SH: Immunology’s foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9, 705–712 (2008).

    Kaufmann S.H. , 'Immunology’s foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff ' (2008 ) 9 Nat Immunol : 705 -712 .

    • Search Google Scholar
  • Ehrlich P et al.: Zur Theorie der Lysenwirkung [in German]. Berlin Klin Woch 36, 6 (1899).

    Ehrlich P. , 'Zur Theorie der Lysenwirkung [in German] ' (1899 ) 36 Berlin Klin Woch : 6 -.

    • Search Google Scholar
  • Witesbsky E: Ehrlich’s side-chain theory in the light of present immunology. Ann N Y Acad Sci 59, 168–181 (1954).

    Witesbsky E. , 'Ehrlich’s side-chain theory in the light of present immunology ' (1954 ) 59 Ann N Y Acad Sci : 168 -181 .

    • Search Google Scholar
  • Ferrata A: Berlin Klin Woch 44, 366 (1907).

    Ferrata A. , '' (1907 ) 44 Berlin Klin Woch : 366 -.

  • Brand E: Berlin Klin Woch 46, 1075 (1907).

    Brand E. , '' (1907 ) 46 Berlin Klin Woch : 1075 -.

  • Omorokow Z: Immunitätsforsh 10, 285 (1911).

    Omorokow Z. , '' (1911 ) 10 Immunitätsforsh : 285 -.

  • Whitehead HR et al.: The “third component” or heat-stable factor of complement. Biochem J 19, 618–625 (1925).

    Whitehead H.R. , 'The “third component” or heat-stable factor of complement ' (1925 ) 19 Biochem J : 618 -625 .

    • Search Google Scholar
  • Coca AF: Z Immunitätsforsh 21, 604 (1914).

    Coca A.F. , '' (1914 ) 21 Z Immunitätsforsh : 604 -.

  • Gordon J et al.: The fourth component of complement and its relation to opsonin. Biochem J 20, 1044–1045 (1926).

    Gordon J. , 'The fourth component of complement and its relation to opsonin ' (1926 ) 20 Biochem J : 1044 -1045 .

    • Search Google Scholar
  • Mayer MM: Development of the one-hit theory of immune hemolysis. Rutgers University Press, New Brunswick, NJ (1961).

    Mayer M.M. , '', in Development of the one-hit theory of immune hemolysis , (1961 ) -.

  • Mayer MM et al.: A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory. J Immunol 105, 327–341 (1970).

    Mayer M.M. , 'A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory ' (1970 ) 105 J Immunol : 327 -341 .

    • Search Google Scholar
  • Inoue K et al.: Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin. Infect Immun 13, 337–344 (1976).

    Inoue K. , 'Evidence for a one-hit theory in the immune bactericidal reaction and demonstration of a multi-hit response for hemolysis by streptolysin O and Clostridium perfringens theta-toxin ' (1976 ) 13 Infect Immun : 337 -344 .

    • Search Google Scholar
  • Morley BJ et al: The complement facts book. Academic Press, UK (2000).

    Morley B.J. , '', in The complement facts book , (2000 ) -.

  • Mayer MM: Studies on the mechanism of hemolysis by antibody and complement. Prog Allergy 5, 215–270 (1958).

    Mayer M.M. , 'Studies on the mechanism of hemolysis by antibody and complement ' (1958 ) 5 Prog Allergy : 215 -270 .

    • Search Google Scholar
  • Muller-Eberhard H et al.: Isolation and description of the fourth component of human complement. J Exp Med 118, 447–466 (1963).

    Muller-Eberhard H. , 'Isolation and description of the fourth component of human complement ' (1963 ) 118 J Exp Med : 447 -466 .

    • Search Google Scholar
  • Nilsson UR et al.: Isolation of beta-IF from human serum and its characterizaion as the fifth component of the complement. J Exp Med 122, 277–298 (1965).

    Nilsson U.R. , 'Isolation of beta-IF from human serum and its characterizaion as the fifth component of the complement ' (1965 ) 122 J Exp Med : 277 -298 .

    • Search Google Scholar
  • Nilsson U: Separation and partial purification of the sixth, seventh and eighth components of human haemolytic complement. Acta Pathol Microbiol Scand 70, 469–480 (1967).

    Nilsson U. , 'Separation and partial purification of the sixth, seventh and eighth components of human haemolytic complement ' (1967 ) 70 Acta Pathol Microbiol Scand : 469 -480 .

    • Search Google Scholar
  • Manni JA et al.: The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency. J Exp Med 130, 1145–1160 (1969).

    Manni J.A. , 'The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency ' (1969 ) 130 J Exp Med : 1145 -1160 .

    • Search Google Scholar
  • Hadding U et al.: The ninth component of human complement: isolation, description and mode of action. Immunology 16, 719–735 (1969).

    Hadding U. , 'The ninth component of human complement: isolation, description and mode of action ' (1969 ) 16 Immunology : 719 -735 .

    • Search Google Scholar
  • Nelson RA Jr, et al.: Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry 3, 111–135 (1966).

    Nelson R.A. , 'Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum ' (1966 ) 3 Immunochemistry : 111 -135 .

    • Search Google Scholar
  • Nelson RA Jr, et al.: Complement components of a haemolytically deficient strain of rabbits. Immunology 14, 527–540 (1968).

    Nelson R.A. , 'Complement components of a haemolytically deficient strain of rabbits ' (1968 ) 14 Immunology : 527 -540 .

    • Search Google Scholar
  • Arumugam TV et al.: Complement mediators in ischemiareperfusion injury. Clin Chim Acta 374, 33–45 (2006).

    Arumugam T.V. , 'Complement mediators in ischemiareperfusion injury ' (2006 ) 374 Clin Chim Acta : 33 -45 .

    • Search Google Scholar
  • Morgan BP: Regulation of the complement membrane attack pathway. Crit Rev Immunol 19, 173–198 (1999).

    Morgan B.P. , 'Regulation of the complement membrane attack pathway ' (1999 ) 19 Crit Rev Immunol : 173 -198 .

    • Search Google Scholar
  • Barrington R et al.: The role of complement in inflammation and adaptive immunity. Immunol Rev 180, 5–15 (2001).

    Barrington R. , 'The role of complement in inflammation and adaptive immunity ' (2001 ) 180 Immunol Rev : 5 -15 .

    • Search Google Scholar
  • Gasque P: Complement: a unique innate immune sensor for danger signals. Mol Immunol 41, 1089–1098 (2004).

    Gasque P. , 'Complement: a unique innate immune sensor for danger signals ' (2004 ) 41 Mol Immunol : 1089 -1098 .

    • Search Google Scholar
  • Ehrnthaller C et al.: New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 17, 317–329 (2011).

    Ehrnthaller C. , 'New insights of an old defense system: structure, function, and clinical relevance of the complement system ' (2011 ) 17 Mol Med : 317 -329 .

    • Search Google Scholar
  • Padilla ND et al.: Creactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Surgery 142, 722–733 (2007).

    Padilla N.D. , 'Creactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion ' (2007 ) 142 Surgery : 722 -733 .

    • Search Google Scholar
  • Pillemer L et al.: The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120, 279–285 (1954).

    Pillemer L. , 'The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena ' (1954 ) 120 Science : 279 -285 .

    • Search Google Scholar
  • Pillemer L: The properdin system. Trans N Y Acad Sci 17, 526–530 (1955).

    Pillemer L. , 'The properdin system ' (1955 ) 17 Trans N Y Acad Sci : 526 -530 .

  • Pillemer L et al.: The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120, 279–285 (1954).

    Pillemer L. , 'The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena ' (1954 ) 120 Science : 279 -285 .

    • Search Google Scholar
  • Arumugam TV et al.: The role of the complement system in ischemia-reperfusion injury. Shock 21, 401–409 (2004).

    Arumugam T.V. , 'The role of the complement system in ischemia-reperfusion injury ' (2004 ) 21 Shock : 401 -409 .

    • Search Google Scholar
  • Thurman JM et al.: The central role of the alternative complement pathway in human disease. J Immunol 176, 1305–1310 (2006).

    Thurman J.M. , 'The central role of the alternative complement pathway in human disease ' (2006 ) 176 J Immunol : 1305 -1310 .

    • Search Google Scholar
  • Ganter MT et al.: Role of the alternative pathway in the early complement activation following major trauma. Shock 28, 29–34 (2007).

    Ganter M.T. , 'Role of the alternative pathway in the early complement activation following major trauma ' (2007 ) 28 Shock : 29 -34 .

    • Search Google Scholar
  • Diepenhorst GM et al.: Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg 249, 889–899 (2009).

    Diepenhorst G.M. , 'Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies ' (2009 ) 249 Ann Surg : 889 -899 .

    • Search Google Scholar
  • Stahl GL et al.: Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 162, 449–455 (2003).

    Stahl G.L. , 'Role for the alternative complement pathway in ischemia/reperfusion injury ' (2003 ) 162 Am J Pathol : 449 -455 .

    • Search Google Scholar
  • Kawasaki T et al.: Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun 81, 1018–1024 (1978).

    Kawasaki T. , 'Isolation and characterization of a mannan-binding protein from rabbit liver ' (1978 ) 81 Biochem Biophys Res Commun : 1018 -1024 .

    • Search Google Scholar
  • Kozutsumi Y et al.: Isolation and characterization of a mannan-binding protein from rabbit serum. Biochem Biophys Res Commun 95, 658–664 (1980).

    Kozutsumi Y. , 'Isolation and characterization of a mannan-binding protein from rabbit serum ' (1980 ) 95 Biochem Biophys Res Commun : 658 -664 .

    • Search Google Scholar
  • Super M et al.: Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2, 1236–1239 (1989).

    Super M. , 'Association of low levels of mannan-binding protein with a common defect of opsonisation ' (1989 ) 2 Lancet : 1236 -1239 .

    • Search Google Scholar
  • Garred P et al.: Deficiency of mannan-binding protein — a recently discovered complement defect syndrome. Ugeskr Laeger 155, 25–29 (1993).

    Garred P. , 'Deficiency of mannan-binding protein — a recently discovered complement defect syndrome ' (1993 ) 155 Ugeskr Laeger : 25 -29 .

    • Search Google Scholar
  • Vorup-Jensen T et al.: Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 165, 2093–2100 (2000).

    Vorup-Jensen T. , 'Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2 ' (2000 ) 165 J Immunol : 2093 -2100 .

    • Search Google Scholar
  • Matsushita M et al.: Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165, 2637–2642 (2000).

    Matsushita M. , 'Proteolytic activities of two types of mannose-binding lectin-associated serine protease ' (2000 ) 165 J Immunol : 2637 -2642 .

    • Search Google Scholar
  • Hajela K et al.: The biological functions of MBL-associated serine proteases (MASPs). Immunobiology 205, 467–475 (2002).

    Hajela K. , 'The biological functions of MBL-associated serine proteases (MASPs) ' (2002 ) 205 Immunobiology : 467 -475 .

    • Search Google Scholar
  • Dahl MR et al.: MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15, 127–135 (2001).

    Dahl M.R. , 'MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway ' (2001 ) 15 Immunity : 127 -135 .

    • Search Google Scholar
  • Matsushita M et al.: Activation of the lectin complement pathway by ficolins. Int Immunopharmacol 1, 359–363 (2001).

    Matsushita M. , 'Activation of the lectin complement pathway by ficolins ' (2001 ) 1 Int Immunopharmacol : 359 -363 .

    • Search Google Scholar
  • Matsushita M et al.: Ficolins and the lectin complement pathway. Immunol Rev 180, 78–85 (2001).

    Matsushita M. , 'Ficolins and the lectin complement pathway ' (2001 ) 180 Immunol Rev : 78 -85 .

    • Search Google Scholar
  • Hansen S et al.: Collectin 11 (CL-11, CL-K1) is a MASP- 1/3-associated plasma collectin with microbial-binding activity. J Immunol 185, 6096–6104 (2010).

    Hansen S. , 'Collectin 11 (CL-11, CL-K1) is a MASP- 1/3-associated plasma collectin with microbial-binding activity ' (2010 ) 185 J Immunol : 6096 -6104 .

    • Search Google Scholar
  • Amara U et al.: Interaction between the coagulation and complement system. Adv Exp Med Biol 632, 71–79 (2008).

    Amara U. , 'Interaction between the coagulation and complement system ' (2008 ) 632 Adv Exp Med Biol : 71 -79 .

    • Search Google Scholar
  • Santizo F et al.: Lectin activity of the coagulation factor VIII/von Willebrand complex. Tohoku J Exp Med 217, 209–215 (2009).

    Santizo F. , 'Lectin activity of the coagulation factor VIII/von Willebrand complex ' (2009 ) 217 Tohoku J Exp Med : 209 -215 .

    • Search Google Scholar
  • Davis AE 3rd: Biological effects of C1 inhibitor. Drug News Perspect 17, 439–446 (2004).

    Davis A.E. , 'Biological effects of C1 inhibitor ' (2004 ) 17 Drug News Perspect : 439 -446 .

    • Search Google Scholar
  • Ikeda K et al.: C5a induces tissue factor activity on endothelial cells. Thromb Haemost 77, 394–398 (1997).

    Ikeda K. , 'C5a induces tissue factor activity on endothelial cells ' (1997 ) 77 Thromb Haemost : 394 -398 .

    • Search Google Scholar
  • Huber-Lang M et al.: Generation of C5a by phagocytic cells. Am J Pathol 161, 1849–1859 (2002).

    Huber-Lang M. , 'Generation of C5a by phagocytic cells ' (2002 ) 161 Am J Pathol : 1849 -1859 .

    • Search Google Scholar
  • Griselli M et al.: C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190, 1733–1740 (1999).

    Griselli M. , 'C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction ' (1999 ) 190 J Exp Med : 1733 -1740 .

    • Search Google Scholar
  • Damman J et al.: Crosstalk between complement and Tolllike receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant 11, 660–669 (2011).

    Damman J. , 'Crosstalk between complement and Tolllike receptor activation in relation to donor brain death and renal ischemia-reperfusion injury ' (2011 ) 11 Am J Transplant : 660 -669 .

    • Search Google Scholar
  • Song WC et al.: Complement and innate immunity. Immunopharmacology 49, 187–198 (2000).

    Song W.C. , 'Complement and innate immunity ' (2000 ) 49 Immunopharmacology : 187 -198 .

    • Search Google Scholar
  • Koski CL et al.: Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. Proc Natl Acad Sci U S A 80, 3816–3820 (1983).

    Koski C.L. , 'Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics ' (1983 ) 80 Proc Natl Acad Sci U S A : 3816 -3820 .

    • Search Google Scholar
  • Morgan BP: Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 264, 1–14 (1989).

    Morgan B.P. , 'Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects ' (1989 ) 264 Biochem J : 1 -14 .

    • Search Google Scholar
  • Tegla CA et al.: Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res 51, 45–60 (2011).

    Tegla C.A. , 'Membrane attack by complement: the assembly and biology of terminal complement complexes ' (2011 ) 51 Immunol Res : 45 -60 .

    • Search Google Scholar
  • Fosbrink M et al.: The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res 31, 37–46 (2005).

    Fosbrink M. , 'The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription ' (2005 ) 31 Immunol Res : 37 -46 .

    • Search Google Scholar
  • Hugli TE: Biochemistry and biology of anaphylatoxins. Complement 3, 111–127 (1986).

    Hugli T.E. , 'Biochemistry and biology of anaphylatoxins ' (1986 ) 3 Complement : 111 -127 .

    • Search Google Scholar
  • Gavrilyuk V et al.: Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of antiinflammatory properties. J Neurochem 92, 1140–1149 (2005).

    Gavrilyuk V. , 'Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of antiinflammatory properties ' (2005 ) 92 J Neurochem : 1140 -1149 .

    • Search Google Scholar
  • de Vries B et al.: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170, 3883–3889 (2003).

    Vries B. , 'Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils ' (2003 ) 170 J Immunol : 3883 -3889 .

    • Search Google Scholar
  • Chenoweth DE et al.: Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 75, 3943–3947 (1978).

    Chenoweth D.E. , 'Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes ' (1978 ) 75 Proc Natl Acad Sci U S A : 3943 -3947 .

    • Search Google Scholar
  • Banz Y et al.: Role of complement and perspectives for intervention in ischemia-reperfusion damage. Ann Med 44, 205–217 (2012).

    Banz Y. , 'Role of complement and perspectives for intervention in ischemia-reperfusion damage ' (2012 ) 44 Ann Med : 205 -217 .

    • Search Google Scholar
  • Foreman KE et al.: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94, 1147–1155 (1994).

    Foreman K.E. , 'C5a-induced expression of P-selectin in endothelial cells ' (1994 ) 94 J Clin Invest : 1147 -1155 .

    • Search Google Scholar
  • Albrecht EA et al.: C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164, 849–859 (2004).

    Albrecht E.A. , 'C5a-induced gene expression in human umbilical vein endothelial cells ' (2004 ) 164 Am J Pathol : 849 -859 .

    • Search Google Scholar
  • Hugli TE: The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit Rev Immunol 1, 321–366 (1981).

    Hugli T.E. , 'The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a ' (1981 ) 1 Crit Rev Immunol : 321 -366 .

    • Search Google Scholar
  • Hugli TE: Structure and function of the anaphylatoxins. Springer Semin Immunopathol 7, 193–219 (1984).

    Hugli T.E. , 'Structure and function of the anaphylatoxins ' (1984 ) 7 Springer Semin Immunopathol : 193 -219 .

    • Search Google Scholar
  • Zhou W: The new face of anaphylatoxins in immune regulation. Immunobiology 217, 225–234 (2012).

    Zhou W. , 'The new face of anaphylatoxins in immune regulation ' (2012 ) 217 Immunobiology : 225 -234 .

    • Search Google Scholar
  • Austen WG Jr et al.: Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126, 343–348 (1999).

    Austen W.G. , 'Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex ' (1999 ) 126 Surgery : 343 -348 .

    • Search Google Scholar
  • Fondevila C et al.: The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury. Liver transpl 14, 1133–1141 (2008).

    Fondevila C. , 'The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury ' (2008 ) 14 Liver transpl : 1133 -1141 .

    • Search Google Scholar
  • Walport MJ: Complement. First of two parts. N Engl J Med 344, 1058–1066 (2001).

    Walport M.J. , 'Complement. First of two parts ' (2001 ) 344 N Engl J Med : 1058 -1066 .

    • Search Google Scholar
  • Walport MJ: Complement. Second of two parts. N Engl J Med 344, 1140–1144 (2001).

    Walport M.J. , 'Complement. Second of two parts ' (2001 ) 344 N Engl J Med : 1140 -1144 .

    • Search Google Scholar
  • Nangaku M: Complement regulatory proteins in glomerular diseases. Kidney Int 54, 1419–1428 (1998).

    Nangaku M. , 'Complement regulatory proteins in glomerular diseases ' (1998 ) 54 Kidney Int : 1419 -1428 .

    • Search Google Scholar
  • Ahearn JM et al.: Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46, 183–219 (1989).

    Ahearn J.M. , 'Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21) ' (1989 ) 46 Adv Immunol : 183 -219 .

    • Search Google Scholar
  • Miwa T et al.: Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int Immunopharmacol 1, 445–459 (2001).

    Miwa T. , 'Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases ' (2001 ) 1 Int Immunopharmacol : 445 -459 .

    • Search Google Scholar
  • Miwa T et al.: Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 48, 363–371 (1998).

    Miwa T. , 'Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1 ' (1998 ) 48 Immunogenetics : 363 -371 .

    • Search Google Scholar
  • Cardone J et al.: CD46 in innate and adaptive immunity: an update. Clin Exp Immunol 164, 301–311 (2011).

    Cardone J. , 'CD46 in innate and adaptive immunity: an update ' (2011 ) 164 Clin Exp Immunol : 301 -311 .

    • Search Google Scholar
  • Lublin DM et al.: Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 7, 35–58 (1989).

    Lublin D.M. , 'Decay-accelerating factor: biochemistry, molecular biology, and function ' (1989 ) 7 Annu Rev Immunol : 35 -58 .

    • Search Google Scholar
  • Davies A et al.: CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170, 637–654 (1989).

    Davies A. , 'CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells ' (1989 ) 170 J Exp Med : 637 -654 .

    • Search Google Scholar
  • Meri S et al.: Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71, 1–9 (1990).

    Meri S. , 'Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers ' (1990 ) 71 Immunology : 1 -9 .

    • Search Google Scholar
  • Li B et al.: Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151, 4295–4305 (1993).

    Li B. , 'Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF ' (1993 ) 151 J Immunol : 4295 -4305 .

    • Search Google Scholar
  • Fraczek LA et al.: Transcriptional control of genes for soluble complement cascade regulatory proteins. Mol Immunol 48, 9–13 (2010).

    Fraczek L.A. , 'Transcriptional control of genes for soluble complement cascade regulatory proteins ' (2010 ) 48 Mol Immunol : 9 -13 .

    • Search Google Scholar
  • Vinci G et al.: In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: tissue distribution and colocalization of their expression. J Immunol 169, 5948–5954 (2002).

    Vinci G. , 'In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: tissue distribution and colocalization of their expression ' (2002 ) 169 J Immunol : 5948 -5954 .

    • Search Google Scholar
  • Ziccardi RJ: The first component of human complement (C1): activation and control. Springer Semin Immunopathol 6, 213–230 (1983).

    Ziccardi R.J. , 'The first component of human complement (C1): activation and control ' (1983 ) 6 Springer Semin Immunopathol : 213 -230 .

    • Search Google Scholar
  • Lappin DF et al.: Effect of interferon-gamma on complement gene expression in different cell types. Biochem J 281, 437–442 (1992).

    Lappin D.F. , 'Effect of interferon-gamma on complement gene expression in different cell types ' (1992 ) 281 Biochem J : 437 -442 .

    • Search Google Scholar
  • Al-Abdullah IH et al.: C1-inhibitor-biochemical properties and clinical applications. Crit Rev Immunol 5, 317–330 (1985).

    Al-Abdullah I.H. , 'C1-inhibitor-biochemical properties and clinical applications ' (1985 ) 5 Crit Rev Immunol : 317 -330 .

    • Search Google Scholar
  • Davis AE 3rd et al.: Biological activities of C1 inhibitor. Mol Immunol 45, 4057–4063 (2008).

    Davis A.E. , 'Biological activities of C1 inhibitor ' (2008 ) 45 Mol Immunol : 4057 -4063 .

    • Search Google Scholar
  • Minta JO et al.: Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene. Gene 208, 17–24 (1998).

    Minta J.O. , 'Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene ' (1998 ) 208 Gene : 17 -24 .

    • Search Google Scholar
  • Kavanagh D et al.: Membrane cofactor protein and factor I: mutations and transplantation. Semin Thromb Hemost 32, 155–159 (2006).

    Kavanagh D. , 'Membrane cofactor protein and factor I: mutations and transplantation ' (2006 ) 32 Semin Thromb Hemost : 155 -159 .

    • Search Google Scholar
  • Kavanagh D et al.: Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16, 2150–2155 (2005).

    Kavanagh D. , 'Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome ' (2005 ) 16 J Am Soc Nephrol : 2150 -2155 .

    • Search Google Scholar
  • Skattum L et al.: Complement deficiency states and associated infections. Mol Immunol 48, 1643–1655 (2011).

    Skattum L. , 'Complement deficiency states and associated infections ' (2011 ) 48 Mol Immunol : 1643 -1655 .

    • Search Google Scholar
  • Farries TC et al.: Competition for binding sites on C3b by CR1, CR2, MCP, factor B and Factor H. Complement Inflamm 7, 30–41 (1990).

    Farries T.C. , 'Competition for binding sites on C3b by CR1, CR2, MCP, factor B and Factor H ' (1990 ) 7 Complement Inflamm : 30 -41 .

    • Search Google Scholar
  • Ferreira VP et al.: Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 47, 2187–2197 (2010).

    Ferreira V.P. , 'Complement control protein factor H: the good, the bad, and the inadequate ' (2010 ) 47 Mol Immunol : 2187 -2197 .

    • Search Google Scholar
  • Atkinson JP et al.: Complement factor H and the hemolytic uremic syndrome. J Exp Med 204, 1245–1248 (2007).

    Atkinson J.P. , 'Complement factor H and the hemolytic uremic syndrome ' (2007 ) 204 J Exp Med : 1245 -1248 .

    • Search Google Scholar
  • Lappin DF et al.: Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem J 271, 767–772 (1990).

    Lappin D.F. , 'Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes ' (1990 ) 271 Biochem J : 767 -772 .

    • Search Google Scholar
  • Fujita T et al.: Characterization of functional properties of C4-binding protein by monoclonal antibodies. J Immunol 134, 3320–3324 (1985).

    Fujita T. , 'Characterization of functional properties of C4-binding protein by monoclonal antibodies ' (1985 ) 134 J Immunol : 3320 -3324 .

    • Search Google Scholar
  • Wenderfer SE et al.: Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. Arthritis Res Ther 9, R114 (2007).

    Wenderfer S.E. , 'Analysis of C4 and the C4 binding protein in the MRL/lpr mouse ' (2007 ) 9 Arthritis Res Ther : R114 -.

    • Search Google Scholar
  • Bokisch VA et al.: Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 49, 2427–2436 (1970).

    Bokisch V.A. , 'Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase ' (1970 ) 49 J Clin Invest : 2427 -2436 .

    • Search Google Scholar
  • Matthews KW et al.: Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol 40, 785–793 (2004).

    Matthews K.W. , 'Carboxypeptidase N: a pleiotropic regulator of inflammation ' (2004 ) 40 Mol Immunol : 785 -793 .

    • Search Google Scholar
  • Skidgel RA et al.: Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int Immunopharmacol 7, 1888–1899 (2007).

    Skidgel R.A. , 'Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator ' (2007 ) 7 Int Immunopharmacol : 1888 -1899 .

    • Search Google Scholar
  • Collapse
  • Expand
  • Top
The author instruction is available in PDF.
Please, download the file from HERE.
 

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI

 

2021  
Web of Science  
Total Cites
WoS
790
Journal Impact Factor not applicable
Rank by Impact Factor not applicable
Impact Factor
without
Journal Self Cites
not applicable
5 Year
Impact Factor
not applicable
Journal Citation Indicator 0,64
Rank by Journal Citation Indicator Microbiology 81/157
Scimago  
Scimago
H-index
not indexed
Scimago
Journal Rank
not indexed
Scimago Quartile Score not indexed
Scopus  
Scopus
Cite Score
not indexed
Scopus
CIte Score Rank
  not indexed
Scopus
SNIP
not indexed

2020  
CrossRef Documents 23
WoS Cites 708
Wos H-index 27
Days from submission to acceptance 219
Days from acceptance to publication 176
Acceptance Rate 70%

2019  
WoS
Cites
558
CrossRef
Documents
24
Acceptance
Rate
92%

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 600 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2022 0 191 118
May 2022 0 153 129
Jun 2022 0 87 70
Jul 2022 0 56 41
Aug 2022 0 75 67
Sep 2022 0 128 93
Oct 2022 0 0 0